Investor Presentaiton slide image

Investor Presentaiton

Investor presentation Full year 2018 Slide 21 Appendix 1. Novo Nordisk at a glance 2. Insulin 22 42 3. GLP-1 diabetes 67 4. Obesity 84 5. Biopharmaceuticals & Other serious chronic diseases 93 6. Financials 105 7. Sustainable business 117 NN: Novo Nordisk changing diabetes® novo nordisk
View entire presentation